PharmAust Limited announced that at its general meeting of shareholders held on August 5, 2013, the shareholders elected Dr. Roger Aston and Professor David Morris as directors of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.175 AUD | -5.41% | -7.89% | +52.17% |
May. 17 | PharmAust Appoints Nonexecutive Chair; Shares Up 3% | MT |
May. 17 | PharmAust Obtains Orphan Drug Designation for Monepantel; Shares Up 5% | MT |
1st Jan change | Capi. | |
---|---|---|
+52.17% | 48.8M | |
+34.35% | 705B | |
+30.78% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.42% | 238B | |
-3.03% | 210B | |
+10.62% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- PAA Stock
- News PharmAust Limited
- PharmAust Limited Elects Roger Aston and David Morris as Directors